Skip to search formSkip to main contentSkip to account menu

89Zr-bevacizumab

Known as: (89)Zr-bevacizumab, Zirconium Zr 89 Bevacizumab 
A radioimmunoconjugate comprised of the recombinant humanized monoclonal antibody bevacizumab labeled with the radioisotope zirconium Zr 89 (Zr 89… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
IntroductionIntravitreal bevacizumab (IVTB) is used to treat age-related macular degeneration (ARMD), although its use is off… 
2014
2014
PurposeThe purpose of this study was to present an atypical case of occult macular dystrophy (OMD) with bilateral chronic… 
Review
2011
Review
2011
Radiation necrosis of normal CNS tissue represents one of the main risk factors of brain irradiation, occurring more frequently… 
Highly Cited
2011
Highly Cited
2011
BackgroundPhotoimmunodetection, in which monoclonal antibodies [mAbs] are labeled with fluorescent dyes, might have clinical… 
Review
2010
Review
2010
OBJECTIVE As the off-label use of intravitreal bevacizumab continues for an increasing number of ocular conditions, a systematic… 
2010
2010
Purpose: The purpose of this study was to report the results of 1-year follow-up examinations after intravitreal bevacizumab… 
Highly Cited
2008
Highly Cited
2008
Purpose: To evaluate the effect of subconjunctival bevacizumab (Avastin) on experimental corneal neovascularization in guinea… 
2007
2007
ZusammenfassungHintergrundDie intravitreale Injektion des Antikörpers Bevacizumab zur Behandlung der neovaskulären AMD findet…